The company is a Korea-based company principally work on the research and development of natural science and engineering. The Company is engaged in the development and manufacture of anticancer vaccines through its platform called CELLSHOT. The company was incorporated on July 8, 2011 and its shares are listed on KONEX Exchange on July 10, 2019.
Headquarters
D-510, 700, Pangyo-Ro, Bundang-Gu
Seongnam; Gyeonggi;
Contact Details: Purchase the Femtobiomed Inc. report to view the information.
Website: http://www.femtobiomed.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service